Vector, a mobile-first workflow automation platform for enterprise shippers, 3PLs, carriers and retailers, recently announced enhancements to its catalog of contactless solutions, including document ...

Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that ...

Versant Ventures has committed $30 million to improve gene delivery. By pumping the cash into Vector BioPharma, the VC is aiming to address the limitations of existing systems such as the cap on the ...

Synthetic gene delivery vectors offer potential advantages over viral vectors for systemic administration. Ease of vector production, customization through conjugation of additional enhancement ...

Vector BioPharma is taking a different approach with a delivery vehicle that’s like a virus, but devoid of the features that limit viral vectors. The Basel, Switzerland-based company formally launched ...

In a recent study posted to the bioRxiv* preprint server, researchers describe a mucosal vector vaccine for targeting dendritic cells. Study: A synthetic delivery vector for mucosal vaccination. Image ...

Gene transfer to lung has been hindered by inflammatory and immunological responses activated to the gene-transfer agent or transgene products. In prior work, adenovirus vector delivered to the lung ...

Vector, a mobile-first workflow automation platform, has enhanced its contactless solutions, including document digitization, mobile workflow automation, and contactless electronic bill of lading ...

Some of the newest and most exciting gene therapy technologies share a problem: They’re too bulky. They rely on multiple functional DNA and protein elements that must reach target cells all at the ...